Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

867 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of Parkinson's disease a review of current and new therapies.
Mendis T, Suchowersky O, Lang A, Gauthier S. Mendis T, et al. Among authors: gauthier s. Can J Neurol Sci. 1999 May;26(2):89-103. Can J Neurol Sci. 1999. PMID: 10352867 Review.
The management of Parkinson's disease has undergone recent changes with the advent of new therapies, both pharmacotherapy and surgery. ...Atypical neuroleptic agents and ECT for psychiatric syndromes associated with Parkinson's disease are discussed. Algorithms for …
The management of Parkinson's disease has undergone recent changes with the advent of new therapies, both pharmacotherapy and surgery …
Current status of levodopa therapy in idiopathic Parkinson's disease.
Gauthier S, Gauthier L. Gauthier S, et al. Among authors: gauthier l. Can J Neurol Sci. 1987 Aug;14(3 Suppl):452-4. doi: 10.1017/s0317167100037902. Can J Neurol Sci. 1987. PMID: 3676919
Levodopa is currently used at all stages of Parkinson's disease, particularly from Stage 3 onward. Most patients start levodopa within four years of the onset of disease, earlier in the akineto-rigid patients (average delay of 2.1 years) than in those where resting tremor …
Levodopa is currently used at all stages of Parkinson's disease, particularly from Stage 3 onward. Most patients start levodopa withi …
Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.
Camicioli R, Gauthier S. Camicioli R, et al. Among authors: gauthier s. Can J Neurol Sci. 2007 Mar;34 Suppl 1:S109-17. doi: 10.1017/s0317167100005679. Can J Neurol Sci. 2007. PMID: 17469693 Review.
Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) are pathological overlapping and important causes of dementia for which clinical trials are in their infancy. ...
Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) are pathological overlapping and important causes of deme …
Recognition and management of neuropsychiatric complications in Parkinson's disease.
Ferreri F, Agbokou C, Gauthier S. Ferreri F, et al. Among authors: gauthier s. CMAJ. 2006 Dec 5;175(12):1545-52. doi: 10.1503/cmaj.060542. CMAJ. 2006. PMID: 17146092 Free PMC article. Review.
Parkinson's disease is primarily considered a motor disease characterized by rest tremor, rigidity, bradykinesia and postural disturbances. ...Changes in mental status have profound implications for the well-being of patients with Parkinson's disease and of their ca …
Parkinson's disease is primarily considered a motor disease characterized by rest tremor, rigidity, bradykinesia and postural disturb …
Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary.
Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, Chris M; 2nd Canadian Conference on Antidementia Guidelines. Feldman HH, et al. Among authors: gauthier s. Can J Neurol Sci. 2006 Feb;33(1):6-26. doi: 10.1017/s0317167100004649. Can J Neurol Sci. 2006. PMID: 16583717 Review.
Alzheimer's disease (AD) accounts for 50-60% of the dementias in later life within a spectrum of other contributing dementias. ...
Alzheimer's disease (AD) accounts for 50-60% of the dementias in later life within a spectrum of other contributing dementias. ...
Outcomes for assessment of symptomatic and stabilization/disease modifying drugs.
Gauthier S. Gauthier S. Can J Neurol Sci. 2007 Mar;34 Suppl 1:S23-6. doi: 10.1017/s0317167100005515. Can J Neurol Sci. 2007. PMID: 17469677 Review.
Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
Gauthier S. Gauthier S. Front Neurol Neurosci. 2009;24:135-139. doi: 10.1159/000197892. Epub 2009 Jan 26. Front Neurol Neurosci. 2009. PMID: 19182471 Review.
Canadian guidelines for the development of antidementia therapies: a conceptual summary.
Mohr E, Feldman H, Gauthier S. Mohr E, et al. Among authors: gauthier s. Can J Neurol Sci. 1995 Feb;22(1):62-71. doi: 10.1017/s0317167100040543. Can J Neurol Sci. 1995. PMID: 7750079
Perhaps the most important concern related to this greying of Canada is the increasing incidence of dementia and Alzheimer's disease. ...
Perhaps the most important concern related to this greying of Canada is the increasing incidence of dementia and Alzheimer's disease. …
A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease.
Rockwood K, Beattie BL, Eastwood MR, Feldman H, Mohr E, Pryse-Phillips W, Gauthier S. Rockwood K, et al. Among authors: gauthier s. Can J Neurol Sci. 1997 May;24(2):140-5. doi: 10.1017/s031716710002148x. Can J Neurol Sci. 1997. PMID: 9164692 Clinical Trial.
OBJECTIVES: We tested the efficacy and safety of linopirdine, a novel phenylindolinone, in the treatment of Alzheimer's disease. ...Further studies may benefit from more sensitive tests of treatment effects in Alzheimer's disease....
OBJECTIVES: We tested the efficacy and safety of linopirdine, a novel phenylindolinone, in the treatment of Alzheimer's disease. ...F …
Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease.
Gauthier S, Bouchard R, Bacher Y, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D, et al. Gauthier S, et al. Can J Neurol Sci. 1989 Nov;16(4 Suppl):543-6. doi: 10.1017/s0317167100029899. Can J Neurol Sci. 1989. PMID: 2680009 Clinical Trial.
Since the discovery of a significant depletion of acetylcholine in discrete areas of the brain of patients affected by Alzheimer's disease, attempts at symptomatic therapy have concentrated on acetylcholine supplementation, an approach that is based upon the efficacy of do …
Since the discovery of a significant depletion of acetylcholine in discrete areas of the brain of patients affected by Alzheimer's di …
867 results
Jump to page
Feedback